Abstract
Objective
To determine the prevalence of group B streptococci (GBS) in our population, and to assess the association between risk factors and vaginal flora with maternal rectovaginal colonization.
Method
Samples were obtained from 405 patients between 35 and 37 weeks of gestation. Swabs from the vaginal and perianal regions were cultured in Todd Hewitt and subcultured in blood agar. Colonies suggestive of GBS were submitted to catalase and CAMP test. The vaginal flora was evaluated on Gram stain vaginal smears. Socio-demographic and obstetric data were obtained by designed form. Considering maternal GBS colonization as the response variable, a logistic regression model was fitted by the stepwise method with quantitative and qualitative explanatory variables.
Results
The prevalence of GBS colonization was 25.4%. The most frequent vaginal flora abnormalities were cytolytic vaginosis (11.3%), followed by bacterial vaginosis (10.9%), candidosis (8.2%) and intermediate vaginal flora II (8.1%). Logistic regression analysis revealed that maternal age, number of sexual intercourse/week, occurrence of previous spontaneous abortion, presence of candidosis and cytolytic vaginosis were associated with streptococcal colonization.
Conclusion
The prevalence of GBS is high in pregnant women and is associated with sexual intercourse frequency, previous spontaneous abortion and the presence of candidosis or cytolytic vaginosis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
During the last few decades, neonatal group B streptococcal (GBS) disease has been associated with significant rates of morbidity and mortality in the perinatal period [1]. GBS is the leading cause of early neonatal sepsis [2]. Maternal streptococcal colonization is also associated with increased risk of urinary tract infection and pregnancy complications, such as endometritis [3] and chorioamnionitis [3, 4], premature delivery and intrauterine death [5]. The main source of neonatal infection is maternal genital tract colonization [6]. GBS is transmitted vertically during labor and delivery and occurs in up to 80% of neonates born to colonized mothers [7].
The Centers for Disease Control and Prevention (CDC) currently recommend screening of all pregnant women for Streptococcus agalactiae between 35 and 37 weeks of gestation [8]. For those with rectovaginal GBS-positive cultures, intravenous penicillin prophylaxis during labor has been recommended and 70% reduction in neonatal early-onset sepsis observed since this strategy was implemented [9].
According to the literature, between 6.5% [10] and 43.6% [11] of pregnant women have S. agalactiae colonized in the vagina or rectum. Maternal colonization rate may vary with population characteristics such as age, parity, socio-economic status, geographic location [12], presence of sexually transmitted diseases [13] and sexual behavior [14]. Differences in colonization rates can be attributed to variation in the culture methods employed, including the media selected and collection sites used [15].
Another important factor associated with pregnancy outcome is the vaginal flora pattern [16]. Lower rates of maternal and perinatal complications are associated with Lactobacillus sp. predominance in the vaginal flora, which plays a key role in protecting the genital tract against infections [17].
Previous studies have demonstrated that vaginal flora composition differs between GBS-positive and GBS-negative women. Women with GBS colonization show a lactobacilli-reduced flora [18, 19] and greater Candida species isolation [19].
Considering the varying rates of maternal GBS colonization in different populations and the high prevalence of vaginal flora alteration during pregnancy, the purpose of this study was to evaluate GBS prevalence in our population and its relationship with risk factors and the vaginal flora pattern.
Materials and methods
This prospective study was conducted at Botucatu Medical School, São Paulo State University, UNESP, between February 2006 and January 2007. Samples were obtained from 405 women at 35 and 37 weeks of gestation and with a singleton pregnancy.
Exclusion criteria were refusal to participate, symptoms of urinary infection or antibiotic use within the preceding 60 days and sexual intercourse within 72 h before examination. The study was approved by the institutional ethics review board, and written informed consent was obtained from all patients. Gynecological and socio-economic data, as well as information on previous gestations, were obtained with a form specifically designed for this study.
For the assessment of GBS status, samples were collected from the vaginal introitus (VI), upper lateral vaginal vault (LV) and perianal region (PR) using different sterile swabs samples were inoculated into non-nutritive Amies transport medium and transported to the microbiology research laboratory. Swabs were removed from the transport medium and inoculated into Todd Hewitt broth supplemented with colistin (10 μg/mL) and nalidixic acid (15 μg/mL). The inoculated broth was incubated for 24 h at 37°C. The broth was subcultured on sheep blood Columbia agar base under the same incubation conditions. Colonies suggestive of S. agalactiae by a narrow zone of beta-hemolytic colonies were submitted to catalase and CAMP test. Negative subculture plates were reincubated for another 18–24 h and reexamined.
Another swab was collected from the mid-third of the vaginal wall for flora evaluation. Gram-stained slides were evaluated and graded to determine the vaginal flora pattern according to Nugent’s criteria [20]. Altered vaginal flora was defined either as flora in which lactobacilli did not predominate (for example, bacterial vaginosis, intermediate flora, aerobic vaginitis) or flora positive for Candida species by microscopy (presence of pseudo hyphae and leukocytes). Mixed infections were defined as those positive for both BV and vaginal candidosis. The presence of more than 25 leukocytes/field on a Gram stain in the absence of trichomonads, candidosis, leptothrix or characteristics of aerobic vaginitis received a designation of “other abnormal flora”. All stained slides were read by experienced observers at the Botucatu Medical School, UNESP, who were blinded to the clinical data.
Considering the presence or absence of maternal GBS colonization as the response variable, a logistic regression model was fitted by the stepwise method with quantitative and qualitative explanatory variables. Statistical analyses were performed with the SAS software, version 9.1. Significance level was set at P < 0.05.
Results
During the study period, 567 patients with gestational age between 35 and 37 weeks presented at the Prenatal Care Unit of Botucatu Medical School. A total of 162 patients were excluded; 106 of them were receiving antibiotics and the other 56 refused to participate in the study. Among the 405 women included in the study, maternal S. agalactiae colonization rate was 25.4%.
The prevalence of vaginal flora alteration was 42.9%: 45.6% in GBS-positive women and 42.1% in women with negative GBS culture. The vaginal flora abnormalities most frequently observed among all pregnant women were cytolytic vaginosis (11.3%), bacterial vaginosis (10.9%), candidosis (8.2%) and intermediate vaginal flora (8.1%), followed by aerobic vaginitis (2.2%) and other altered vaginal flora (1.5%). Mixed infections were present in 0.7% of the evaluated vaginal smears.
Socio-demographic and gestational data of the patients are shown in Table 1. Median maternal age, parity, schooling level, frequency of sexual intercourse, discharge, premature labor, rupture of membranes, previous abortions, and sexually transmitted diseases did not differ between GBS-positive and GBS-negative women.
Logistic regression analysis showed that maternal age, number of sexual intercourses/week, occurrence of previous spontaneous abortion, presence of candidiasis and cytolytic vaginosis were associated with GBS colonization. OD values for all variables associated with GBS colonization are shown in Table 2.
Discussion
In this study, the prevalence of maternal S. agalactiae colonization observed in 405 women was similar to that reported in literature [18, 19, 21]. Given that culture accuracy can be increased depending on the anatomic sites of collection and the microbiologic methods used, S. agalactiae detection was performed in accordance with CDC recommendations [22].
There is evidence that GBS colonization varies according to the socio-economic characteristics of the population studied. In this study, median age was slightly higher in GBS-positive women than in the GBS-negative group, in disagreement with other authors who found higher rates in younger women [23, 24].
GBS colonization also seems to correlate with sexual behavior. The rate of positive GBS cultures is reported to be higher in women who have sexual intercourse more frequently [14]. This finding was confirmed by our results. Moreover, GBS has been demonstrated to play a leading role in spontaneous abortion [25]. The fact that women with GBS colonization in previous gestations are more likely to be colonized in subsequent gestations [26] may explain the association between GBS isolation and previous spontaneous abortion found here.
Our data about vaginal flora indicate a high percentage of abnormal vaginal flora in the third trimester of gestation. The importance of this finding lies on the fact that pregnant women with altered vaginal ecosystem detected by Gram stain evaluation are at increased risk for adverse gestational outcome [27].
According to literature, vaginal flora composition in pregnant women with GBS colonization correlates inversely with lactobacilli counts [18, 19] and directly with Candida species isolation [19]. In this study, Gram smear examination showed that GBS colonization was associated with candidosis and cytolytic vaginosis. On the other hand, Honig et al. [28] observed no correlation between GBS-positive cultures and vaginal flora alteration, such as bacterial vaginosis, candidosis and co-infection by Trichomonas vaginalis or Neisseria gonorrhoeae and Chlamydia trachomatis endocervicitis. Considering that the rates of Candida species isolation are higher in women with GBS-positive vaginal flora, development into vulvovaginal candidosis is more likely to occur among them.
No previous study has assessed the association between cytolytic vaginosis and GBS colonization. However, the large number of subjects included in this study allows the establishment of this association. Cytolytic vaginosis is commonly misdiagnosed as vaginal candidosis due to the similarity of symptoms. The symptoms of cytolytic vaginosis are caused by the release of irritant cytoplasmic components, which result from lactobacilli overgrowth [29].
In brief, our results show that the prevalence of GBS in the study population was high; and there was association between maternal GBS colonization and sexual intercourse frequency, previous spontaneous abortion and the presence of candidosis or cytolytic vaginosis.
References
Schrag SJ, Zywicki S, Farley MM et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342:15–20
Schuchat A (1998) Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 11:497–513
Winn HN (2007) Group B streptococcus infection in pregnancy. Clin Perinatol 34:387–392. doi:10.1016/j.clp.2007.03.012
Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P (1994) Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 84:816–819
Tyrrel GL, Senzilet LD, Spika JS et al (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population based, active laboratory surveillance study-1996. J Infect Dis 182:168–173. doi:10.1086/315699
Boyer KM, Gotoff SP (1985) Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 35:267–280
Schuchat A (1995) Epidemiology of group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 49:19–25
Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention (1996) MMWR Recomm Rep 45:1–24
Baltimore RS (2007) Consequences of prophylaxis for group B streptococcal infections of the neonate. Semin Perinatol 31:33–38. doi:10.1053/j.semperi.2007.01.005
Yücesoy G, Calişkan E, Karadenizli A et al (2004) Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis. Int J Clin Pract 58:735–739. doi:10.1111/j.1368-5031.2004.00025.x
Gavino M, Wang E (2007) A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol 197:388.e1–4. doi:10.1016/j.ajog.2007.06.016
Regan JA, Klebanoff MA, Nugent RP (1991) The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 77:604–610
Persson K, Bjerre B, Hansson H, Forsgren A (1981) Several factors influencing the colonization of group B streptococci—rectum probably the main reservoir. Scand J Infect Dis 13:171–175
Foxman B, Gillespie BW, Manning SD, Marrs CF (2007) Risk factors for group B streptococcal colonization: potential for different transmission systems by capsular type. Ann Epidemiol 17:854–862. doi:10.1016/j.annepidem.2007.05.014
Davies HD, Adair CE, Partlow ES, Sauve R, Low DE, McGeer A (1999) Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs. Diagn Microbiol Infect Dis 35:169–176
Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G (2004) Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 190:1509–1519. doi:10.1016/j.ajog.2004.01.002
Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA (1992) The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 79:369–373
Kubota T (1998) Relationship between maternal group B streptococcal colonization and regnancy outcome. Obstet Gynecol 92:926–930
Altoparlack U, Kadanali A, Kadanali S (2004) Genital flora in pregnancy and its association with group B streptococcal colonization. Int J Gynaecol Obstet 87:245–256. doi:10.1016/j.ijgo.2004.08.006
Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301
Heelan JS, Struminsky J, Lauro P, Sung CJ (2005) Evaluation of a new selective enrichment broth for detection of group B streptococci in pregnant women. J Clin Microbiol 43:896–897. doi:10.1128/JCM.43.2.896-897.2005
Schrag S, Gorwitz PR, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group b streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 16:1–22
Moyo SR, Mudzori J, Tswana SA, Maeland JA (2000) Prevalence, capsular type distribution, anthropometric and obstetric factors of group B streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent Afr J Med 46:115–120
Kadanali A, Altoparlak U, Kadanali S (2005) Maternal carriage and neonatal colonisation of group B streptococcus in eastern Turkey: prevalence, risk factors and antimicrobial resistance. Int J Clin Pract 59:437–440. doi:10.1111/j.1368-5031.2005.00395.x
McDonald HM, Chambers HM (2000) Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor? Infect Dis Obstet Gynecol 8:220–227. doi:10.1155/S1064744900000314
Turrentine M, Ramirez M (2007) Prevalence of group B streptococci (GBS) colonization in subsequent pregnancies. Am J Obstet Gynecol 10:S69. doi:10.1016/j.ajog.2007.10.222
Klein LL, Gibbs RS (2005) Infection and preterm birth. Obstet Gyneco Clin North Am 2:397–410. doi:10.1016/j.ogc.2005.03.001
Honig E, Mouton JW, Van der Meijden WI (2002) Epidemiology of vaginal colonisation with group B streptococci in a sexually transmitted disease clinic. Eur J Obstet Gynecol Reprod Biol 105:177–180. doi:10.1016/S0301-2115(02)00162-8
Cibley LJ, Cibley LJ (1991) Cytolytic vaginosis. Am J Obstet Gynecol 165:1245–1249
Acknowledgments
The authors are thankful to Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) for providing financial support to this work (grant 06/55307-0 and 07/51704-7).
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rocchetti, T.T., Marconi, C., Rall, V.L.M. et al. Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora. Arch Gynecol Obstet 283, 717–721 (2011). https://doi.org/10.1007/s00404-010-1439-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1439-8